Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F19QG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $196,811
Award facts
- Contract value 100% obligated
- $196,811.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $196,811.26 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on December 16, 2025, with completion expected by December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Dupixent (dupilumab) is a biologic medication commonly prescribed for moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, making this procurement essential for military medical readiness and veteran healthcare services. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to meet complex pharmaceutical procurement requirements for the Defense Health Agency and other federal healthcare systems through open competition, with this delivery order representing a component of the company's critical role as a pharmaceutical prime vendor supporting global military medical operations.
Quick answers
Who was awarded contract SPE2DR26F19QG?
SPE2DR26F19QG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F19QG worth?
The government has obligated $196,811 on SPE2DR26F19QG.
Is contract SPE2DR26F19QG an order under another contract?
Yes. SPE2DR26F19QG is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19QG competed?
The extent of competition for SPE2DR26F19QG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award